Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keigo Hara

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Anticancer Research|February 11, 2014
L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancerMakoto Sohda, Hiroaki Honjyo, Keigo Hara, et al.
Anticancer Research|February 29, 2024
Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal CancerMakoto Sohda, Keigo Hara, Kengo Kuriyama, et al.
Anticancer Research|April 4, 2021
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) <i>vs</i>. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical SettingMakoto Sakai, Makoto Sohda, Hideyuki Saito, et al.
Anticancer Research|December 16, 2014
L-[3-¹⁸F]-α-methyltyrosine uptake by lymph node metastasis is a predictor of complete response to CRT in esophageal cancerMakoto Sohda, Tatsuya Miyazaki, Hiroaki Honjyo, et al.
Surgical Case Reports|January 23, 2023
Gangrenous ischemic colitis localized to the cecum: a case reportKohei Tateno, Yoko Motegi, Hiroomi Ogawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2015
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patientsBolag Altan, Takehiko Yokobori, Munenori Ide, et al.
Cancer Science|April 18, 2020
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinomaKengo Kuriyama, Tamami Higuchi, Takehiko Yokobori, et al.
Annals of Surgical Oncology|June 13, 2020
CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell CarcinomaTomonori Yoshida, Takehiko Yokobori, Hideyuki Saito, et al.
Annals of Surgical Oncology|August 28, 2015
Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell CarcinomaTakehiko Yokobori, Pinjie Bao, Minoru Fukuchi, et al.
Scientific Reports|May 12, 2021
Thyroid hormone activated upper gastrointestinal motility without mediating gastrointestinal hormones in conscious dogsNobuhiro Nakazawa, Makoto Sohda, Kyoichi Ogata, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Anticancer Research|February 11, 2014
L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancerMakoto Sohda, Hiroaki Honjyo, Keigo Hara, et al.
Anticancer Research|February 29, 2024
Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal CancerMakoto Sohda, Keigo Hara, Kengo Kuriyama, et al.
Anticancer Research|April 4, 2021
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) <i>vs</i>. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical SettingMakoto Sakai, Makoto Sohda, Hideyuki Saito, et al.
Anticancer Research|December 16, 2014
L-[3-¹⁸F]-α-methyltyrosine uptake by lymph node metastasis is a predictor of complete response to CRT in esophageal cancerMakoto Sohda, Tatsuya Miyazaki, Hiroaki Honjyo, et al.
Surgical Case Reports|January 23, 2023
Gangrenous ischemic colitis localized to the cecum: a case reportKohei Tateno, Yoko Motegi, Hiroomi Ogawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2015
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patientsBolag Altan, Takehiko Yokobori, Munenori Ide, et al.
Cancer Science|April 18, 2020
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinomaKengo Kuriyama, Tamami Higuchi, Takehiko Yokobori, et al.
Annals of Surgical Oncology|June 13, 2020
CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell CarcinomaTomonori Yoshida, Takehiko Yokobori, Hideyuki Saito, et al.
Annals of Surgical Oncology|August 28, 2015
Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell CarcinomaTakehiko Yokobori, Pinjie Bao, Minoru Fukuchi, et al.
Scientific Reports|May 12, 2021
Thyroid hormone activated upper gastrointestinal motility without mediating gastrointestinal hormones in conscious dogsNobuhiro Nakazawa, Makoto Sohda, Kyoichi Ogata, et al.
Pageof 7